Using too much of this medicine may increase the chance of unwanted effects. This medicine should come with a Medication Guide. Read and follow these instructions carefully. Feldene Gel, generally called as Piroxicam, is the brand name of a non-steroidal anti-inflammatory agent (NSAID) along with analgesic and antipyretic properties. It is topically used for treating acute soft tissue injuries like sprains, strains and tendonitis no more than two weeks. What is Feldene? Feldene is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis. Feldene may also be used for purposes not listed in this medication guide. Detailed dosage guidelines and administration information for Feldene (piroxicam). Includes dose adjustments, warnings and precautions. Feldene (Piroxicam) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. The project that produced piroxicam began in 1962 at Pfizer; the first clinical trial results were reported in 1977, and the product launched in 1980 under the brand name Feldene. [7][12] Major patents expired in 1992 [7] and the drug is marketed worldwide under many brandnames. FELDENE is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activities in animal models. The mechanism of action of FELDENE, like that. Piroxicam (Feldene) is a nonsteroidal anti-inflammatory drug (NSAID) that works well to relieve symptoms of arthritis, such as joint pain, swelling, and stiffness. It's a capsule that's taken by mouth, typically once daily. Possible side effects include diarrhea, nausea, vomiting, and rash. Overview: Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID). It is used for arthritis symptoms like pain and swelling. Common side effects include nausea, vomiting, constipation or. Feldene is commonly used for symptomatic relief in conditions characterized by periods of heightened symptoms and localized discomfort. It addresses symptom clusters that may become disruptive, particularly those related to physical discomfort and inflammatory or irritative states in the joints.